185
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Inhibitory effects of 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside on experimental inflammation and cyclooxygenase 2 activity

, , , &
Pages 355-363 | Received 16 Nov 2005, Accepted 14 Mar 2006, Published online: 03 Jul 2007
 

Abstract

The inhibitory effects of 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside (THSG), extracted from the roots of Polygonum multiflorum Thunb, on inflammatory activity in animal models and cyclooxygenase-2 (COX-2) activity in lipopolysaccharide (LPS)-induced mouse RAW264.7 macrophage cells were investigated. The carrageenin (CGN)-induced rat paw oedema model and dimethylbenzene-induced mouse ear oedema model were prepared; MTT assay, semi-quantitative RT-PCR, Western blot and ELISA were adopted. THSG 2.3, 4.6 and 9.2 mg kg− 1 by oral administration inhibited mouse ear oedema and the percentage of inhibition of THSG 9.2 mg kg− 1 is 87%. THSG 3.2, 6.4 and 12.8 mg kg− 1 by oral administration dose-dependently inhibited rat paw oedema and the percentage of inhibition of THSG 12.8 mg kg− 1 is 56% at 6 h. Indomethacin 13 and 9 mg kg− 1 showed 90% and 57% inhibition in the same animal models, respectively. LPS 1 μg ml− 1 significantly up-regulated prostaglandin E2 (PGE2) production (inducing COX-2 activity) by 35% (exogenous arachidonic acid, AA), which was dose-dependently decreased by THSG 1, 10, and 100 μmol L− 1 and the percentage of inhibition of THSG 10 μmol L− 1 was 40%. NS-398 10 μmol L− 1 decreased PGE2 production by 42%. THSG 1, 10, 100 μmol L− 1 was shown to markedly inhibit the LPS-induced COX-2 protein and mRNA expression in RAW264.7 cells (P < 0.05) but had no effect on COX-1 protein and mRNA (P>0.05). In summary, the data showed that THSG possessed an anti-inflammatory effect, which was perhaps related to the inhibition of COX-2 enzyme activity and expression in RAW264.7 macrophage cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.